Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Braud

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2015
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancerL Barault, A Amatu, F E Bleeker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogramF Pietrantonio, R Miceli, L Rimassa, et al.
ESMO Open|August 5, 2021
Skip pattern approach toward the early access of innovative anticancer drugsG Apolone, A Ardizzoni, A Biondi, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE studyP Andena, G Tine, F Nichetti, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2023
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic reviewA Prelaj, V Miskovic, M Zanitti, et al.
ESMO Open|January 5, 2021
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohortU Peretti, A Cavaliere, M Niger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglectedF Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
ESMO Open|November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)F Spada, F Gelsomino, M Rinzivillo, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2015
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancerL Barault, A Amatu, F E Bleeker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogramF Pietrantonio, R Miceli, L Rimassa, et al.
ESMO Open|August 5, 2021
Skip pattern approach toward the early access of innovative anticancer drugsG Apolone, A Ardizzoni, A Biondi, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of diabetes mellitus on treatment efficacy in patients with advanced pancreatic cancer: the Italian, multicenter, observational PANCAKE studyP Andena, G Tine, F Nichetti, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2023
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic reviewA Prelaj, V Miskovic, M Zanitti, et al.
ESMO Open|January 5, 2021
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohortU Peretti, A Cavaliere, M Niger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglectedF Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
ESMO Open|November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)F Spada, F Gelsomino, M Rinzivillo, et al.
Pageof 12